(VIANEWS) – Shares of Arcturus Therapeutics (ARCT) jumped by a staggering 11.01% to $49.69 at 10:23 EST on Thursday, after three consecutive sessions in a row of gains. NASDAQ Composite is rising 0.34% to $14,830.70, after three sequential sessions in a row of gains. This seems, up to now, a somewhat up trend trading session today.

Arcturus Therapeutics’s last close was $58.25, 55.09% under its 52-week high of $129.71.


Today’s last reported volume for Arcturus Therapeutics is 392388 which is 39.63% below its average volume of 649957.

Arcturus Therapeutics’s Revenue

Year-on-year quarterly revenue growth declined by 19.6%, now sitting on 9.02M for the twelve trailing months.


Arcturus Therapeutics’s last week, last month’s, and last quarter’s current volatility was a positive 1.27%, a negative 0.20%, and a positive 3.35%, respectively.

Arcturus Therapeutics’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (last week), 3.22% (last month), and 3.35% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Arcturus Therapeutics’s stock is considered to be oversold (<=20).

Arcturus Therapeutics’s Stock Yearly Top and Bottom Value

Arcturus Therapeutics’s stock is valued at $49.69 at 10:23 EST, way under its 52-week high of $129.71 and way higher than its 52-week low of $24.87.

Arcturus Therapeutics’s Moving Average

Arcturus Therapeutics’s worth is way above its 50-day moving average of $33.21 and way above its 200-day moving average of $43.21.

More news about Arcturus Therapeutics (ARCT).


Please enter your comment!
Please enter your name here